CP
CHE icon

Castleview Partners’s Chemed CHE Stock Holding History

Castleview Partners’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$11K Buy
+23
New +$11K ﹤0.01% 660

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Castleview Partners's CHE Position: Q2 2021 in Review

Castleview Partners opened a new position in Chemed (CHE) in Q2 2021: 23 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #660 among its holdings.

425 funds tracked by Wall St. Rank hold CHE as of Q2 2021.

  • Castleview Partners held 23 shares of Chemed worth $11K as of Q2 2021.
  • Chemed was a new Castleview Partners position in Q2 2021.
  • Chemed made up ﹤0.01% of Castleview Partners's portfolio in Q2 2021, its #660 holding.
  • 425 funds tracked by Wall St. Rank held Chemed as of Q2 2021.

Based on Castleview Partners's 13F filing for Q2 2021, filed 17 Aug 2021.